ISPIRE TECHNOLOGY INC (ISPR) Stock Fundamental Analysis

NASDAQ:ISPR • US46501C1009

2.75 USD
-0.26 (-8.64%)
At close: Feb 18, 2026
2.75 USD
0 (0%)
After Hours: 2/18/2026, 5:39:25 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ISPR. ISPR was compared to 8 industry peers in the Tobacco industry. Both the profitability and financial health of ISPR have multiple concerns. While showing a medium growth rate, ISPR is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • ISPR had negative earnings in the past year.
  • In the past year ISPR has reported a negative cash flow from operations.
  • ISPR had negative earnings in 4 of the past 5 years.
  • In the past 5 years ISPR reported 4 times negative operating cash flow.
ISPR Yearly Net Income VS EBIT VS OCF VS FCFISPR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 0 -10M -20M -30M

1.2 Ratios

  • ISPR has a worse Return On Assets (-38.26%) than 87.50% of its industry peers.
Industry RankSector Rank
ROA -38.26%
ROE N/A
ROIC N/A
ROA(3y)-19.02%
ROA(5y)-11.16%
ROE(3y)-2183.71%
ROE(5y)-1309.14%
ROIC(3y)N/A
ROIC(5y)N/A
ISPR Yearly ROA, ROE, ROICISPR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 0 -2K -4K -6K

1.3 Margins

  • With a Gross Margin value of 16.98%, ISPR is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of ISPR has grown nicely.
  • ISPR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.56%
GM growth 5YN/A
ISPR Yearly Profit, Operating, Gross MarginsISPR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025 0 10 -10 -20 -30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • ISPR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ISPR has more shares outstanding than it did 1 year ago.
  • The debt/assets ratio for ISPR is higher compared to a year ago.
ISPR Yearly Shares OutstandingISPR Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
ISPR Yearly Total Debt VS Total AssetsISPR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • Based on the Altman-Z score of 0.45, we must say that ISPR is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.45, ISPR is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.45
ROIC/WACCN/A
WACC8.97%
ISPR Yearly LT Debt VS Equity VS FCFISPR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 0 10M -10M 20M -20M 30M

2.3 Liquidity

  • ISPR has a Current Ratio of 1.14. This is a normal value and indicates that ISPR is financially healthy and should not expect problems in meeting its short term obligations.
  • ISPR has a Current ratio (1.14) which is comparable to the rest of the industry.
  • A Quick Ratio of 1.05 indicates that ISPR should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.05, ISPR is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 1.05
ISPR Yearly Current Assets VS Current LiabilitesISPR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • ISPR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -156.20%.
  • ISPR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.07%.
  • ISPR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.11% yearly.
EPS 1Y (TTM)-156.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.29%
Revenue 1Y (TTM)-16.07%
Revenue growth 3Y13.11%
Revenue growth 5YN/A
Sales Q2Q%-51.5%

3.2 Future

  • The Earnings Per Share is expected to grow by 41.94% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 14.85% on average over the next years. This is quite good.
EPS Next Y88.17%
EPS Next 2Y41.94%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-6.31%
Revenue Next 2Y14.85%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ISPR Yearly Revenue VS EstimatesISPR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M
ISPR Yearly EPS VS EstimatesISPR Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0 -0.2 -0.4 -0.6

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ISPR. In the last year negative earnings were reported.
  • Based on the Price/Forward Earnings ratio of 269.61, the valuation of ISPR can be described as expensive.
  • 75.00% of the companies in the same industry are cheaper than ISPR, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 28.16. ISPR is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 269.61
ISPR Price Earnings VS Forward Price EarningsISPR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150 200 250

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ISPR Per share dataISPR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5 2

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • ISPR's earnings are expected to grow with 41.94% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.94%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • ISPR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ISPIRE TECHNOLOGY INC

NASDAQ:ISPR (2/18/2026, 5:39:25 PM)

After market: 2.75 0 (0%)

2.75

-0.26 (-8.64%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryTobacco
Earnings (Last)02-06
Earnings (Next)05-11
Inst Owners8.46%
Inst Owner Change-0.29%
Ins Owners4.18%
Ins Owner Change-0.86%
Market Cap157.55M
Revenue(TTM)127.49M
Net Income(TTM)-36.90M
Analysts82.86
Price Target6.63 (141.09%)
Short Float %3.27%
Short Ratio13.06
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-20.45%
Min EPS beat(2)-82.07%
Max EPS beat(2)41.18%
EPS beat(4)1
Avg EPS beat(4)-48.05%
Min EPS beat(4)-96.08%
Max EPS beat(4)41.18%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-41.67%
Min Revenue beat(2)-52.54%
Max Revenue beat(2)-30.8%
Revenue beat(4)1
Avg Revenue beat(4)-24.12%
Min Revenue beat(4)-52.54%
Max Revenue beat(4)6.1%
Revenue beat(8)2
Avg Revenue beat(8)-20.64%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-13.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)87.5%
EPS NY rev (1m)0%
EPS NY rev (3m)57.89%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-30.51%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-30.66%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 269.61
P/S 1.33
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.63
EYN/A
EPS(NY)0.01
Fwd EY0.37%
FCF(TTM)-0.23
FCFYN/A
OCF(TTM)-0.21
OCFYN/A
SpS2.07
BVpS-0.03
TBVpS-0.07
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -38.26%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 16.98%
FCFM N/A
ROA(3y)-19.02%
ROA(5y)-11.16%
ROE(3y)-2183.71%
ROE(5y)-1309.14%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.56%
GM growth 5YN/A
F-Score3
Asset Turnover1.23
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 217.1%
Cap/Sales 1.06%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 1.05
Altman-Z 0.45
F-Score3
WACC8.97%
ROIC/WACCN/A
Cap/Depr(3y)1019.5%
Cap/Depr(5y)849.8%
Cap/Sales(3y)1.52%
Cap/Sales(5y)0.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-156.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.29%
EPS Next Y88.17%
EPS Next 2Y41.94%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-16.07%
Revenue growth 3Y13.11%
Revenue growth 5YN/A
Sales Q2Q%-51.5%
Revenue Next Year-6.31%
Revenue Next 2Y14.85%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-93.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year119.32%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y56.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y59.71%
OCF growth 3YN/A
OCF growth 5YN/A

ISPIRE TECHNOLOGY INC / ISPR FAQ

What is the ChartMill fundamental rating of ISPIRE TECHNOLOGY INC (ISPR) stock?

ChartMill assigns a fundamental rating of 2 / 10 to ISPR.


What is the valuation status of ISPIRE TECHNOLOGY INC (ISPR) stock?

ChartMill assigns a valuation rating of 1 / 10 to ISPIRE TECHNOLOGY INC (ISPR). This can be considered as Overvalued.


Can you provide the profitability details for ISPIRE TECHNOLOGY INC?

ISPIRE TECHNOLOGY INC (ISPR) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for ISPR stock?

The Earnings per Share (EPS) of ISPIRE TECHNOLOGY INC (ISPR) is expected to grow by 88.17% in the next year.